Workflow
Generative AI services
icon
Search documents
Why Is Cognizant (CTSH) Down 0.1% Since Last Earnings Report?
ZACKS· 2025-08-29 16:31
Core Viewpoint - Cognizant Technology Solutions reported strong Q2 2025 earnings, beating estimates and showing year-over-year revenue growth, driven by acquisitions and organic growth in key sectors [3][4][12]. Financial Performance - Non-GAAP earnings per share for Q2 2025 were $1.31, exceeding the Zacks Consensus Estimate by 3.97% and reflecting a 12% increase year-over-year [3]. - Revenues reached $5.25 billion, surpassing the consensus mark by 1.01%, with an 8.1% year-over-year increase and a 7.2% increase at constant currency [3]. - The Belcan acquisition contributed approximately 400 basis points to revenue growth [4]. - Bookings for the trailing 12 months increased by 6% year-over-year to $27.8 billion, with a book-to-bill ratio of approximately 1.4 times [4]. Segment Performance - Financial Services revenues, accounting for 29.5% of total revenues, grew by 6.9% year-over-year to $1.547 billion [6]. - Health Sciences revenues, also 29.6% of total revenues, increased by 6.2% year-over-year to $1.551 billion [6]. - Products and Resources revenues rose by 16% year-over-year to $1.306 billion, while Communications, Media and Technology revenues increased by 3.1% to $841 million [7]. Geographic Performance - North America revenues grew by 8.1% year-over-year, contributing 74.6% to total revenues [7]. - Europe revenues increased by 9.6% year-over-year, contributing 19.1% to total revenues, with the U.K. and Continental Europe showing respective increases of 8.6% and 10.6% [8]. Operational Metrics - Selling, general & administrative expenses as a percentage of revenues decreased by 70 basis points year-over-year to 15.4% [9]. - The company reported a GAAP operating margin of 15.6%, expanding by 100 basis points year-over-year [10]. - Total headcount increased to 343,800 from 336,300 in the previous quarter [9]. Balance Sheet - Cash and short-term investments totaled $1.80 billion as of June 30, 2025, down from $1.99 billion as of March 31, 2025 [11]. - Total debt decreased to $592 million from $600 million in the previous quarter [11]. - Free cash flow was reported at $331 million, compared to $393 million in the prior quarter [11]. Guidance - For Q3 2025, Cognizant expects revenues between $5.27 billion and $5.35 billion, indicating growth of 4.6%-6.1% [12]. - For the full year 2025, revenues are projected to be between $20.7 billion and $21.1 billion, reflecting a growth of 4.7%-6.7% [12]. - Adjusted earnings per share for 2025 are anticipated to be between $5.08 and $5.22 [13]. Market Position - Estimates for Cognizant have trended upward over the past month, indicating positive market sentiment [14][16]. - The company holds a Zacks Rank 3 (Hold), suggesting an expectation of in-line returns in the near term [16].
Cognizant Q2 Earnings Beat Estimates: Will Raised View Aid Shares?
ZACKS· 2025-07-31 18:11
Core Insights - Cognizant Technology Solutions (CTSH) reported non-GAAP earnings of $1.31 per share for Q2 2025, exceeding the Zacks Consensus Estimate by 3.97% and reflecting a 12% year-over-year increase [1] - Revenues reached $5.25 billion, surpassing the consensus mark by 1.01%, with an 8.1% year-over-year growth and a 7.2% increase at constant currency [1] - The Belcan acquisition played a significant role in revenue growth, contributing approximately 400 basis points to overall results [2] Financial Performance - Bookings for the trailing 12 months increased by 6% year over year to $27.8 billion, with a book-to-bill ratio of approximately 1.4 times [2] - Financial services revenues, accounting for 29.5% of total revenues, grew by 6.9% year over year to $1.547 billion [4] - Health Sciences revenues, also 29.6% of total revenues, increased by 6.2% year over year to $1.551 billion, driven by strong demand across various sectors [4] Revenue Breakdown - Products and Resources revenues, making up 24.9% of total revenues, rose by 16% year over year to $1.306 billion [5] - Communications, Media and Technology revenues were $841 million, reflecting a 3.1% year-over-year increase [5] - North America contributed 74.6% to total revenues, with an 8.1% year-over-year growth [5][6] Regional Performance - Revenues from Europe increased by 9.6% year over year, contributing 19.1% to total revenues [6] - The U.K. saw an 8.6% year-over-year revenue increase, while Continental Europe revenues grew by 10.6% [6] - Revenues from the Rest of the World increased by 4.7% year over year, contributing 6.3% to total revenues [6] Operational Metrics - Selling, general & administrative expenses as a percentage of revenues decreased by 70 basis points year over year to 15.4% [9] - Total headcount rose to 343,800 from 336,300 in the previous quarter [9] - GAAP operating margin improved by 100 basis points year over year to 15.6% [9][10] Guidance and Future Outlook - Cognizant expects Q3 2025 revenues between $5.27 billion and $5.35 billion, indicating growth of 4.6%-6.1% [12] - For the full year 2025, revenues are projected to be in the range of $20.7-$21.1 billion, reflecting a growth of 4.7%-6.7% [12] - Adjusted earnings per share for 2025 are anticipated to be between $5.08 and $5.22 [13]
Cognizant Q1 Earnings Beat Estimates: Will Raised View Aid Shares?
ZACKS· 2025-05-01 18:25
Core Insights - Cognizant Technology Solutions (CTSH) reported non-GAAP earnings of $1.23 per share for Q1 2025, exceeding the Zacks Consensus Estimate by 3.36% and reflecting a year-over-year increase of 9.8% [1] - Revenues reached $5.12 billion, surpassing the consensus mark by 0.95%, with a year-over-year growth of 7.5% and 8.2% at constant currency [1] - The Belcan acquisition contributed approximately 400 basis points to revenue growth, while bookings increased 3% year over year to $26.7 billion, indicating a book-to-bill ratio of about 1.3 times [2] Financial Performance - Financial services revenues, accounting for 28.6% of total revenues, grew 5.6% year over year to $1.462 billion, driven by increased discretionary spending and investments in cloud and AI [4] - Health Sciences revenues, making up 30.7% of total revenues, rose 10.9% year over year to $1.571 billion, supported by strong demand across various sectors [5] - Products and Resources revenues increased 12.8% year over year to $1.27 billion, while Communications, Media and Technology revenues decreased 2.7% to $804 million [5] Regional Performance - North America contributed 75.3% to total revenues, with a year-over-year increase of 9.5% [6] - Revenues from Europe grew 1.2% year over year, contributing 18.6% to total revenues, while the Rest of the World saw a 3.7% increase [6] Operational Metrics - Selling, general & administrative expenses as a percentage of revenues decreased by 60 basis points year over year to 15.5% [7] - The company reported a GAAP operating margin of 16.7%, expanding 210 basis points year over year, and a non-GAAP operating margin of 15.5%, which expanded 40 basis points [8] Balance Sheet Overview - As of March 31, 2025, cash and short-term investments totaled $1.99 billion, down from $2.24 billion at the end of 2024 [9] - Total debt decreased to $600 million from $908 million, while cash generated from operations was $400 million compared to $920 million in the previous quarter [9] Future Guidance - For Q2 2025, revenues are expected to be between $5.14 billion and $5.21 billion, indicating growth of 5.9%-7.4% [10] - For the full year 2025, revenues are projected to be in the range of $20.5-$21 billion, reflecting an increase of 3.9-6.4% [10] - Adjusted earnings per share for 2025 are anticipated to be between $4.98 and $5.14 [11]